IP Library Granted Patent US 9,873,669
Granted Patent B2
US 9,873,669 · App. 15/109,512 · Granted Jan 23, 2018

Cationic lipid

Inventors: Yuta Suzuki (Tsukuba, JP); Kenji Hyodo (Tsukuba, JP); Yohei Tanaka (Nakama, JP)
Assignees: Eisai R&D Management Co., Ltd.; Sogo Pharmaceutical Co., Ltd.
C07D211/62A61K9/5123A61K47/22A61K48/0033C07D205/04C07D207/16C12N15/111C12N15/1137C12N2310/14C12N2320/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,873,669
App. No.
15/109,512
Granted
Jan 23, 2018
Kind
B2
Abstract

The present invention provides a cationic lipid which can be used for nucleic acid delivery to a cytoplasm and which is possible to solve the problem of physical stability of a lipid complex. This cationic lipid is a compound represented by the general formula (3) or a pharmaceutically acceptable salt thereof: wherein, L is an alkyl having 7-12 carbon atoms or an alkenyl having 7-12 carbon atoms, R is an alkyl having 1-2 carbon atoms, and n 1 and n 2 are independently an integer of 1-3.

Claims (7)

1. A cationic lipid which is a compound represented by formula (3) or a pharmaceutically acceptable salt thereof:

wherein L is an alkyl having 7-12 carbon atoms or an alkenyl having 7-12 carbon atoms,

R is an alkyl having 1-2 carbon atoms, and

n 1 and n 2 are each 2.

2. The cationic lipid according to claim 1 , wherein the cationic lipid is a compound selected from the following compounds (4), (6), and (8)-(11) or a pharmaceutically acceptable salt thereof:

3. The cationic lipid according to claim 1 , wherein the cationic lipid is a compound represented by the following formula (4) or a pharmaceutically acceptable salt thereof:

4. The cationic lipid according to claim 1 , wherein the cationic lipid is a compound represented by the following formula (10) or a pharmaceutically acceptable salt thereof:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2016
From: SUZUKI, YUTA; HYODO, KENJI; TANAKA, YOHEI
To: EISAI R&D MANAGEMENT CO., LTD.; SOGO PHARMACEUTICAL CO., LTD.
Reel/Frame 039178/0832 →
Continuity (2)
Provisional Application 61925267 · Jan 9, 2014
Related Publication 20160326116A1 · Nov 10, 2016